These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 6158494

  • 1. Endothelial fenestrae in proliferative diabetic retinopathy.
    Wallow IH, Geldner PS.
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1176-83. PubMed ID: 6158494
    [Abstract] [Full Text] [Related]

  • 2. Subretinal neovascularization complicating laser photocoagulation of diabetic maculopathy.
    Lewen RM.
    Ophthalmic Surg; 1988 Oct; 19(10):734-7. PubMed ID: 2461540
    [Abstract] [Full Text] [Related]

  • 3. [Panphotocoagulation in simple and proliferative diabetic retinopathy].
    Mirkiewicz-Sieradzka B, Romanowska B, Zygulska-Machowa H.
    Klin Oczna; 1988 Sep; 90(9):317-9. PubMed ID: 2469824
    [No Abstract] [Full Text] [Related]

  • 4. Chorioretinal and choriovitreal neovascularization after photocoagulation for proliferative diabetic retinopathy. A clinicopathologic correlation.
    Wallow I, Johns K, Barry P, Chandra S, Bindley C.
    Ophthalmology; 1985 Apr; 92(4):523-32. PubMed ID: 2582332
    [Abstract] [Full Text] [Related]

  • 5. Time span of regression or disappearance of optic disk neovascularisation in proliferative diabetic retinopathy after panretinal argon laser photocoagulation and results over a two-year follow-up.
    Theodossiadis GP, Ismiridis KJ.
    Fortschr Ophthalmol; 1987 Apr; 84(5):465-7. PubMed ID: 2448214
    [No Abstract] [Full Text] [Related]

  • 6. Development of clustered fenestrae of chorioretinal vessels in pathologic conditions.
    Kohno T.
    Osaka City Med J; 1993 Nov; 39(2):151-66. PubMed ID: 8183535
    [Abstract] [Full Text] [Related]

  • 7. Ultrastructural characteristics of new vessels in proliferative diabetic retinopathy.
    Williams JM, de Juan E, Machemer R.
    Am J Ophthalmol; 1988 May 15; 105(5):491-9. PubMed ID: 2453120
    [Abstract] [Full Text] [Related]

  • 8. [Results of panretinal photocoagulation in preproliferative and proliferative ischemic diabetic retinopathy: apropos of 235 eyes followed for 6 months to 8 years].
    Annonier MP, Soubrane G, Coscas G.
    Bull Soc Ophtalmol Fr; 1986 Nov 15; 86(11):1363-6. PubMed ID: 2438059
    [No Abstract] [Full Text] [Related]

  • 9. [Diabetic maculopathy and proliferative retinopathy: their relation and the results of photocoagulation].
    Nikolić Lj, Radović N.
    Srp Arh Celok Lek; 1985 Aug 15; 113(8):655-63. PubMed ID: 2418513
    [No Abstract] [Full Text] [Related]

  • 10. Management of proliferative diabetic retinopathy.
    Gündüz K, Bakri SJ.
    Compr Ophthalmol Update; 2007 Aug 15; 8(5):245-56. PubMed ID: 18201511
    [Abstract] [Full Text] [Related]

  • 11. Laser treatment in diabetic retinopathy.
    O'Donoghue HN.
    Trans Ophthalmol Soc U K (1962); 1982 Aug 15; 102 (Pt 4)():468-70. PubMed ID: 6194597
    [Abstract] [Full Text] [Related]

  • 12. Current options in management: proliferative diabetic eye disease.
    Barrie T.
    Trans Ophthalmol Soc U K (1962); 1983 Aug 15; 103 ( Pt 2)():125-32. PubMed ID: 6198786
    [No Abstract] [Full Text] [Related]

  • 13. Diabetic neovascularization: permeability and ultrastructure.
    Miller H, Miller B, Zonis S, Nir I.
    Invest Ophthalmol Vis Sci; 1984 Nov 15; 25(11):1338-42. PubMed ID: 6208163
    [Abstract] [Full Text] [Related]

  • 14. The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model.
    Wolbarsht ML, Landers MB.
    Ophthalmic Surg; 1980 Apr 15; 11(4):235-45. PubMed ID: 6155650
    [Abstract] [Full Text] [Related]

  • 15. Limitations of successful photocoagulation in proliferative diabetic retinopathy.
    Freyler H, Klemen U, Egerer I.
    Mod Probl Ophthalmol; 1979 Apr 15; 20():396-400. PubMed ID: 95031
    [No Abstract] [Full Text] [Related]

  • 16. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
    Gendron RL, Good WV, Adams LC, Paradis H.
    Invest Ophthalmol Vis Sci; 2001 Nov 15; 42(12):3000-7. PubMed ID: 11687548
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Panretinal photocoagulation and proliferative diabetic retinopathy. Results of a long-term prospective study (2d report)].
    Chaine G, Zerah I, Coscas G.
    Bull Soc Ophtalmol Fr; 1986 Nov 15; 86(11):1369-72. PubMed ID: 2438060
    [No Abstract] [Full Text] [Related]

  • 19. [Comparative study of diabetic retinopathy lesions of the posterior pole and retinal periphery in 200 diabetics].
    Devlamynck S, Bondu G.
    Bull Soc Ophtalmol Fr; 1982 Dec 15; 82(12):1593-6. PubMed ID: 6191882
    [No Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW.
    Invest Ophthalmol Vis Sci; 1997 Jan 15; 38(1):36-47. PubMed ID: 9008628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.